Cristina Vera-Mansilla
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Cristina Vera-Mansilla has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
- Alberto Gutiérrez-Calvo
Hospital Universitario Príncipe de Asturias, General and Digestive Surgery Department, Alcalá de Henares, Spain
6 shared publications - Ana Quiroga-Valcárcel
Hospital Universitario Príncipe de Asturias, General and Digestive Surgery Department, Alcalá de Henares, Spain
6 shared publications - Belén Matías-García
General Surgery, Príncipe de Asturias Teaching Hospital, Alcalá de Henares, ESP
6 shared publications - Enrique Ovejero-Merino
Hospital Universitario Príncipe de Asturias, General and Digestive Surgery Department, Alcalá de Henares, Spain
6 shared publications - Fernando Mendoza-Moreno
Department of General and Digestive Surgery, Príncipe de Asturias Teaching Hospital, 28805 Alcalá de Henares, Spain
6 shared publications - Manuel Díez-Alonso
Department of General Surgery, Príncipe de Asturias Hospital, 28801 Alcalá de Henares, Spain
6 shared publications
Latest Publications
- Open Access
- 31 January 2026
- Published by Impact Health in Impact Surgery
- Vol. 3 (1) , 370-375
Predictors of rupture and mortality in uncommon true visceral artery aneurysms: A protocol for a systematic review and pooled analysis.
Background: Visceral artery aneurysms (VAAs) are rare vascular lesions associated with a substantial risk of rupture and high mortality. Splenic artery aneurysms (SAAs) are the most common and best studied, with relatively well-established risk factors and management strategies. In contrast, uncommon VAAs arising from the hepatic, celiac, superior mesenteric, gastroduodenal, pancreaticoduodenal, gastroepiploic, gastric, jejunal, ileal, colic, and inferior mesenteric arteries are exceedingly rare, and their natural history and rupture predictors remain poorly defined. Rupture has been reported at small diameters, challenging size-based thresholds derived largely from SAA data. Objectives: This systematic review and pooled analysis aims to determine rupture rates, predictors of rupture, and rupture-related mortality of uncommon true VAAs, and to compare these outcomes with those reported for SAAs, which will serve as reference lesions. Methods: The review will be conducted in accordance with PRISMA 2020 guidelines and is registered in PROSPERO (CRD420251155062). A comprehensive search of PubMed/MEDLINE, Embase, Web of Science, Scopus, and Google Scholar will be performed. For uncommon VAAs, eligible studies will include meta-analyses, systematic reviews, cohort studies, case series, and case reports. For SAAs, only meta-analyses, systematic reviews, and large cohort studies will be included. Pooled patient-level data will be extracted where available. Primary outcomes are rupture rate and rupture-related mortality; secondary outcomes include predictors of rupture according to aneurysm location, size, patient characteristics, and clinical presentation. Risk of bias will be assessed using JBI, ROBINS-I, and AMSTAR 2 tools. Expected Impact: This review aims to clarify rupture behaviour of uncommon VAAs, identify clinically relevant predictors, and provide a stronger evidence base to support risk stratification and harmonisation of clinical decision-making.
- 31 January 2026
- Published by Impact Health in Impact Surgery
- Vol. 3 (1) , 370-375
Open AccessPredictors of rupture and mortality in uncommon true visceral artery aneurysms: A protocol for a systematic review and pooled analysis.
Background: Visceral artery aneurysms (VAAs) are rare vascular lesions associated with a substantial risk of rupture and high mortality. Splenic artery aneurysms (SAAs) are the most common and best studied, with relatively well-established risk factors and management strategies. In contrast, uncommon VAAs arising from the hepatic, celiac, superior mesenteric, gastroduodenal, pancreaticoduodenal, gastroepiploic, gastric, jejunal, ileal, colic, and inferior mesenteric arteries are exceedingly rare, and their natural history and rupture predictors remain poorly defined. Rupture has been reported at small diameters, challenging size-based thresholds derived largely from SAA data. Objectives: This systematic review and pooled analysis aims to determine rupture rates, predictors of rupture, and rupture-related mortality of uncommon true VAAs, and to compare these outcomes with those reported for SAAs, which will serve as reference lesions. Methods: The review will be conducted in accordance with PRISMA 2020 guidelines and is registered in PROSPERO (CRD420251155062). A comprehensive search of PubMed/MEDLINE, Embase, Web of Science, Scopus, and Google Scholar will be performed. For uncommon VAAs, eligible studies will include meta-analyses, systematic reviews, cohort studies, case series, and case reports. For SAAs, only meta-analyses, systematic reviews, and large cohort studies will be included. Pooled patient-level data will be extracted where available. Primary outcomes are rupture rate and rupture-related mortality; secondary outcomes include predictors of rupture according to aneurysm location, size, patient characteristics, and clinical presentation. Risk of bias will be assessed using JBI, ROBINS-I, and AMSTAR 2 tools. Expected Impact: This review aims to clarify rupture behaviour of uncommon VAAs, identify clinically relevant predictors, and provide a stronger evidence base to support risk stratification and harmonisation of clinical decision-making.
- Open Access
- 22 August 2022
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (16) , 4922
Prognostic Factors of Survival in Patients with Peritoneal Metastasis from Colorectal Cancer
Objectives: The aim of this study was to analyze the prognostic factors of survival in patients with peritoneal metastasis (PM) from colorectal cancer (CRC). The type of relationship between survival and the PM time of detection was used to determine whether it was synchronous with the primary tumor or metachronous. Patients and Methods: Retrospective observational study. It included patients treated for colorectal adenocarcinoma diagnosed between January 2005 and December 2019 who presented PM at the time of diagnosis or during follow-up. Variables, such as sex, age, differentiation grade, positive adenopathy (pN+), tumor size (pT), tumor location, mucinous component, peritoneal carcinomatosis index (PCI), and KRAS mutational status, were analyzed. Results: During the study period, 1882 patients were surgically treated for CRC in our hospital. Of these, 240 patients (12.8%) were included in the study after evidence of PM. The mean age was 67 ± 12 years (range: 32–92 years), and 114 patients were female (47.5%). The mean follow-up was 20 ± 13 months (median 12 months). The Kaplan–Meier survival at 36 months was higher in patients with metachronous PM (24% vs. 8%; p = 0.002), WT-KRAS tumors (31% vs. 15%; p < 0.001), N0 stage (30% vs. 19%; p < 0.001), T3 stage tumors (18% vs. 19% in T4A and 3% in T4B; p > 0.001), and tumors with classic adenocarcinoma histology (18% vs. 8%; p = 0.011). Patients with a PCI of 1–10 showed a likelihood of survival at 36 months of 56%, which was longer than that found in patients with a PCI of 11–20 (8%) or a PCI of >20 (0%) (p < 0.001). In the multiple regression analysis, the factors with an independent prognostic value were: poor grade of differentiation (HR 1.995; 95% CI: 1.294–3.077), KRAS mutation (HR 1.751; 95% CI: 1.188–2.581), PCI 11–20 (HR: 9.935; 95% CI: 5.204–18.966) and PCI > 20 (HR: 4.011; 95% CI: 2.291–7.023). Conclusions: PCI should continue as the as the most useful prognostic indicator in order to assess prognostic estimations as well as therapeutic and surgical decisions, but tumor grade and KRAS mutational status may help in the treatment decision process by providing complementary information. The time of PM detection did not achieve statistical significance in the multiple regression analysis.
- 22 August 2022
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (16) , 4922
Open AccessPrognostic Factors of Survival in Patients with Peritoneal Metastasis from Colorectal Cancer
Objectives: The aim of this study was to analyze the prognostic factors of survival in patients with peritoneal metastasis (PM) from colorectal cancer (CRC). The type of relationship between survival and the PM time of detection was used to determine whether it was synchronous with the primary tumor or metachronous. Patients and Methods: Retrospective observational study. It included patients treated for colorectal adenocarcinoma diagnosed between January 2005 and December 2019 who presented PM at the time of diagnosis or during follow-up. Variables, such as sex, age, differentiation grade, positive adenopathy (pN+), tumor size (pT), tumor location, mucinous component, peritoneal carcinomatosis index (PCI), and KRAS mutational status, were analyzed. Results: During the study period, 1882 patients were surgically treated for CRC in our hospital. Of these, 240 patients (12.8%) were included in the study after evidence of PM. The mean age was 67 ± 12 years (range: 32–92 years), and 114 patients were female (47.5%). The mean follow-up was 20 ± 13 months (median 12 months). The Kaplan–Meier survival at 36 months was higher in patients with metachronous PM (24% vs. 8%; p = 0.002), WT-KRAS tumors (31% vs. 15%; p < 0.001), N0 stage (30% vs. 19%; p < 0.001), T3 stage tumors (18% vs. 19% in T4A and 3% in T4B; p > 0.001), and tumors with classic adenocarcinoma histology (18% vs. 8%; p = 0.011). Patients with a PCI of 1–10 showed a likelihood of survival at 36 months of 56%, which was longer than that found in patients with a PCI of 11–20 (8%) or a PCI of >20 (0%) (p < 0.001). In the multiple regression analysis, the factors with an independent prognostic value were: poor grade of differentiation (HR 1.995; 95% CI: 1.294–3.077), KRAS mutation (HR 1.751; 95% CI: 1.188–2.581), PCI 11–20 (HR: 9.935; 95% CI: 5.204–18.966) and PCI > 20 (HR: 4.011; 95% CI: 2.291–7.023). Conclusions: PCI should continue as the as the most useful prognostic indicator in order to assess prognostic estimations as well as therapeutic and surgical decisions, but tumor grade and KRAS mutational status may help in the treatment decision process by providing complementary information. The time of PM detection did not achieve statistical significance in the multiple regression analysis.
- 24 February 2022
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 48 (2) , e129-e130
Survival analysis and disease-free survival in pancreatic neuroendocrine tumors. Experience in a single center.
- 24 February 2022
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 48 (2) , e129-e130
Survival analysis and disease-free survival in pancreatic neuroendocrine tumors. Experience in a single center.
- 24 February 2022
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 48 (2) , e104
Does the extent of lymphadenectomy and the presence of positive lymphadenopathy influence survival and disease-free interval after left hemicolectomy?
- 24 February 2022
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 48 (2) , e104
Does the extent of lymphadenectomy and the presence of positive lymphadenopathy influence survival and disease-free interval after left hemicolectomy?
- 24 February 2022
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 48 (2) , e103
Risk factors for anastomotic leakage after total colectomy in patients with colorectal carcinoma.
- 24 February 2022
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 48 (2) , e103
Risk factors for anastomotic leakage after total colectomy in patients with colorectal carcinoma.
- 24 February 2022
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 48 (2) , e110
Chemotherapy as the first therapeutic option in patients with stage IV colorectal cancer with non resecable synchronic liver metastasis.
- 24 February 2022
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 48 (2) , e110
Chemotherapy as the first therapeutic option in patients with stage IV colorectal cancer with non resecable synchronic liver metastasis.
- Open Access
- 5 October 2021
- Published by S. Karger AG in Visceral Medicine
- Vol. 38 (1) , 72-77
Surgical Treatment of Gallstone Ileus: Less Is More
Introduction: The objective of this study was to evaluate the need for cholecystectomy in patients who underwent surgery for gallstone ileus. Methods: This was a retrospective review of the clinical history of patients who underwent surgery for gallstone ileus between December 1992 and December 2018 and follow-up until October 2020. Data regarding the surgical intervention, location of the obstruction, and surgical procedure performed were collected, as well as complications in relation to biliary pathology in the postoperative period. Results: Twenty-five patients underwent surgery for gallstone ileus. In all patients, except one, the site of the obstruction was identified. The mean age of the patients was 72 (standard deviation [SD] 13.3) years, with a female predominance (18: 7). The patients presented symptoms, on average, 2.9 (1–7) days before going to the emergency room; the primary symptoms were vomiting associated with abdominal pain and constipation (56%). Fifty-six percent of patients were diagnosed preoperatively by imaging tests. In 72% of patients, an enterolithotomy was performed alone without any other intervention on the gallbladder or bile duct. Eighty-three percent of the patients did not present any cholecystobiliary complications during the entire follow-up period, and urgent or delayed cholecystectomy was not performed after the acute episode. Conclusions: Gallstone ileus is a rare entity, and there are no randomized studies that support a preferred treatment. If surgical intervention is required, enterotomy for stone extraction is a safe and effective technique, and in our experience, urgent or delayed cholecystectomy is not necessary.
- 5 October 2021
- Published by S. Karger AG in Visceral Medicine
- Vol. 38 (1) , 72-77
Open AccessSurgical Treatment of Gallstone Ileus: Less Is More
Introduction: The objective of this study was to evaluate the need for cholecystectomy in patients who underwent surgery for gallstone ileus. Methods: This was a retrospective review of the clinical history of patients who underwent surgery for gallstone ileus between December 1992 and December 2018 and follow-up until October 2020. Data regarding the surgical intervention, location of the obstruction, and surgical procedure performed were collected, as well as complications in relation to biliary pathology in the postoperative period. Results: Twenty-five patients underwent surgery for gallstone ileus. In all patients, except one, the site of the obstruction was identified. The mean age of the patients was 72 (standard deviation [SD] 13.3) years, with a female predominance (18: 7). The patients presented symptoms, on average, 2.9 (1–7) days before going to the emergency room; the primary symptoms were vomiting associated with abdominal pain and constipation (56%). Fifty-six percent of patients were diagnosed preoperatively by imaging tests. In 72% of patients, an enterolithotomy was performed alone without any other intervention on the gallbladder or bile duct. Eighty-three percent of the patients did not present any cholecystobiliary complications during the entire follow-up period, and urgent or delayed cholecystectomy was not performed after the acute episode. Conclusions: Gallstone ileus is a rare entity, and there are no randomized studies that support a preferred treatment. If surgical intervention is required, enterotomy for stone extraction is a safe and effective technique, and in our experience, urgent or delayed cholecystectomy is not necessary.
- Open Access
- 15 September 2021
- Published by Microbiology Society in Access Microbiology
- Vol. 3 (9) , 000261
Clostridium perfringens necrotizing pancreatitis: an unusual pathogen in pancreatic necrosis infection
Pancreatic necrosis infection (PNI) accounts for about 20–40 % of severe acute pancreatitis. PNI caused by anaerobic bacteria is unusual but when they present, Clostridium perfringens is the microorganism most commonly involved. We present a 60-year-old patient with a previous history of SARS-CoV-2, diagnosed with acute pancreatitis. During the hospitalisation he developed Clostridium perfringens bacteraemia. A CT-scan showed pancreatic gas gangrene and a surgical necrosectomy was performed. Clostridium perfringens was isolated in cultures of the pancreatic tissue and collections. The patient’s clinical status improved after surgery and the appropriate medical therapy. He was discharged 76 days after admission. Nowadays, the ‘step-up approach’ is an accepted therapeutic tool in treatment of pancreatic necrosis and peripancreatic fluid collections. However, most authors suggest that Clostridum perfringens infection requires a more aggressive approach due to the high mortality associated to clostridial infection.
- 15 September 2021
- Published by Microbiology Society in Access Microbiology
- Vol. 3 (9) , 000261
Open AccessClostridium perfringens necrotizing pancreatitis: an unusual pathogen in pancreatic necrosis infection
Pancreatic necrosis infection (PNI) accounts for about 20–40 % of severe acute pancreatitis. PNI caused by anaerobic bacteria is unusual but when they present, Clostridium perfringens is the microorganism most commonly involved. We present a 60-year-old patient with a previous history of SARS-CoV-2, diagnosed with acute pancreatitis. During the hospitalisation he developed Clostridium perfringens bacteraemia. A CT-scan showed pancreatic gas gangrene and a surgical necrosectomy was performed. Clostridium perfringens was isolated in cultures of the pancreatic tissue and collections. The patient’s clinical status improved after surgery and the appropriate medical therapy. He was discharged 76 days after admission. Nowadays, the ‘step-up approach’ is an accepted therapeutic tool in treatment of pancreatic necrosis and peripancreatic fluid collections. However, most authors suggest that Clostridum perfringens infection requires a more aggressive approach due to the high mortality associated to clostridial infection.
- Open Access
- 26 February 2021
- Published by Wiley in Case Reports in Surgery
- Vol. 2021, 1-7
Unusual Case of Gallbladder Adenocarcinoma Metastasis to the Abdominal Wall 11 Years Later: Synchronous Presentation with Two Malignant Colon Tumors, Coincidence or Not?
Introduction. Abdominal wall masses are a common finding in clinical practice. A high percentage of these masses are malignant. We present the case of a patient operated for a gallbladder adenocarcinoma, who consulted eleven years later for a malignant mass of the abdominal wall in synchrony with two adenocarcinomas of the left colon and sigmoid. Case Report. A 75-year-old male underwent a laparoscopic cholecystectomy with an incidental diagnosis of adenocarcinoma in situ (TisN0M0 according to AJCC 8th edition). The operative report mentioned that the removal of the gallbladder was difficult due to the inflammatory process, and the gallbladder was accidentally opened during the operation. It was not clear from the operative report whether an extraction bag was utilized to remove the specimen, but the histopathological study confirmed an open gallbladder. He presented 11 years later with an asymptomatic heterogeneous complex cystic mass involving the anterior rectus abdominis muscle. Colonoscopy showed synchronous tumors in the descending and sigmoid colon with pathology confirming adenocarcinoma. The patient underwent an elective laparotomy with resection of the anterior abdominal wall mass, left hemicolectomy, and sigmoidectomy. The histopathological results of the abdominal mass (CK7, CK20, EMA, CEA positive) were described as metastasis of adenocarcinoma of biliary origin. Discussion. Port site recurrences are rare complications following laparoscopic surgery when malignancy is unsuspected. Possible factors related to local implantation include direct seeding of spilled bile or tumor cells into the wound or shedding of tumor cells due to pneumoperitoneum-induced loss of the peritoneal barrier at the trocar site. In the absence of distant metastasis, treatment should include wide port site excision with malignancy-free surgical margins. Conclusion. Abdominal wall metastasis from gallbladder carcinoma is rare, and its synchronous presentation with a malignant neoplasm of the colon is exceptional. This is the first report of a patient with abdominal wall metastasis from a gallbladder adenocarcinoma operated eleven years ago that debuted synchronously with two adenocarcinomas of the left colon and sigma.
- 26 February 2021
- Published by Wiley in Case Reports in Surgery
- Vol. 2021, 1-7
Open AccessUnusual Case of Gallbladder Adenocarcinoma Metastasis to the Abdominal Wall 11 Years Later: Synchronous Presentation with Two Malignant Colon Tumors, Coincidence or Not?
Introduction. Abdominal wall masses are a common finding in clinical practice. A high percentage of these masses are malignant. We present the case of a patient operated for a gallbladder adenocarcinoma, who consulted eleven years later for a malignant mass of the abdominal wall in synchrony with two adenocarcinomas of the left colon and sigmoid. Case Report. A 75-year-old male underwent a laparoscopic cholecystectomy with an incidental diagnosis of adenocarcinoma in situ (TisN0M0 according to AJCC 8th edition). The operative report mentioned that the removal of the gallbladder was difficult due to the inflammatory process, and the gallbladder was accidentally opened during the operation. It was not clear from the operative report whether an extraction bag was utilized to remove the specimen, but the histopathological study confirmed an open gallbladder. He presented 11 years later with an asymptomatic heterogeneous complex cystic mass involving the anterior rectus abdominis muscle. Colonoscopy showed synchronous tumors in the descending and sigmoid colon with pathology confirming adenocarcinoma. The patient underwent an elective laparotomy with resection of the anterior abdominal wall mass, left hemicolectomy, and sigmoidectomy. The histopathological results of the abdominal mass (CK7, CK20, EMA, CEA positive) were described as metastasis of adenocarcinoma of biliary origin. Discussion. Port site recurrences are rare complications following laparoscopic surgery when malignancy is unsuspected. Possible factors related to local implantation include direct seeding of spilled bile or tumor cells into the wound or shedding of tumor cells due to pneumoperitoneum-induced loss of the peritoneal barrier at the trocar site. In the absence of distant metastasis, treatment should include wide port site excision with malignancy-free surgical margins. Conclusion. Abdominal wall metastasis from gallbladder carcinoma is rare, and its synchronous presentation with a malignant neoplasm of the colon is exceptional. This is the first report of a patient with abdominal wall metastasis from a gallbladder adenocarcinoma operated eleven years ago that debuted synchronously with two adenocarcinomas of the left colon and sigma.
- Open Access
- 1 January 2018
- Published by Wolters Kluwer Health in International Journal of Surgery Case Reports
- Vol. 48 (C) , 50-53
Presentation of a large jejunal artery aneurysm
Introduction: Jejunal artery aneurysms (JAAs) constitute less than 1% of all visceral artery aneurysms. They affect mostly men in their fifth decade. In the last years, the widespread of fine cut fine image techniques has increased the number of JAAs diagnosed incidentally. The first case was reported by Levine in 1944. Since then, only a half of hundred cases have been reported. There is a lack of consensus of management of intact JAAs because of the low number of cases published. We present the largest JAA reported in the English literature up to our knowledge. Presentation: We report a 49 year-old woman with a 4 × 5 cm. intact jejunal artery aneurysm found incidentally in a CT. It rose from the first jejunal branch of superior mesenteric artery without signs of rupture. She underwent elective surgery and the aneurysm was completely excised. Discussion: Causes of JAAs include congenital, atherosclerosis or degenerative process. Their rate of rupture depends on location, size and underlying disease and it reaches 10-20% for all visceral artery aneurysms. Risk factors of rupture include pregnancy, hyper-flow situations and connective diseases. Most of cases in the literature presented rupture at the time of diagnosis. JAAs are usually treated following the recommendations for visceral artery aneurysms, so intact JAAs greater than 2 cm. and those causing symptoms should be treated. Treatment includes surgery, embolisation or stent. Surgery is the preferred management for emergency settings. Conclusion: JAAs are extremely rare and constitute only 1% of all visceral aneurysms. They are a life-threatening condition. Highlights:
- 1 January 2018
- Published by Wolters Kluwer Health in International Journal of Surgery Case Reports
- Vol. 48 (C) , 50-53
Open AccessPresentation of a large jejunal artery aneurysm
Introduction: Jejunal artery aneurysms (JAAs) constitute less than 1% of all visceral artery aneurysms. They affect mostly men in their fifth decade. In the last years, the widespread of fine cut fine image techniques has increased the number of JAAs diagnosed incidentally. The first case was reported by Levine in 1944. Since then, only a half of hundred cases have been reported. There is a lack of consensus of management of intact JAAs because of the low number of cases published. We present the largest JAA reported in the English literature up to our knowledge. Presentation: We report a 49 year-old woman with a 4 × 5 cm. intact jejunal artery aneurysm found incidentally in a CT. It rose from the first jejunal branch of superior mesenteric artery without signs of rupture. She underwent elective surgery and the aneurysm was completely excised. Discussion: Causes of JAAs include congenital, atherosclerosis or degenerative process. Their rate of rupture depends on location, size and underlying disease and it reaches 10-20% for all visceral artery aneurysms. Risk factors of rupture include pregnancy, hyper-flow situations and connective diseases. Most of cases in the literature presented rupture at the time of diagnosis. JAAs are usually treated following the recommendations for visceral artery aneurysms, so intact JAAs greater than 2 cm. and those causing symptoms should be treated. Treatment includes surgery, embolisation or stent. Surgery is the preferred management for emergency settings. Conclusion: JAAs are extremely rare and constitute only 1% of all visceral aneurysms. They are a life-threatening condition. Highlights: